Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1350193
                    [Title] => FDA approves Gilead Sciences drug for 3 cancers
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer.

                    [DatePublished] => 2014-07-25 07:01:42
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1265295
                    [Title] => FDA approves breakthrough hepatitis C drug
                    [Summary] => 
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.

                    [DatePublished] => 2013-12-07 07:32:52
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1510054
                    [AuthorName] => Matthew Perrone
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img4.imageshack.us/img4/181/l7wd.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 842936
                    [Title] => US approves 4-in-1 HIV combination pill
                    [Summary] => 
The U.S. Food and Drug Administration on Monday approved a new anti-HIV pill that combines four medicines to combat the virus that causes AIDS.
                    [DatePublished] => 2012-08-28 11:21:35
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 836861
                    [Title] => HIV prevention pill for heterosexuals at risk too
                    [Summary] => 
U.S. health officials said Thursday that doctors  should consider giving an AIDS prevention pill to women and heterosexual  men who are at high risk for getting the virus.
                    [DatePublished] => 2012-08-10 01:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 833309
                    [Title] => DOH mulling adoption of preventive medication for HIV
                    [Summary] => 
The Department of Health (DOH) is studying the possibility of adopting preventive medication for HIV/AIDS that was approved by the United States’ Food and Drug Administration.
                    [DatePublished] => 2012-07-31 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 706063
                    [Title] => Pills prevent HIV in straight men and women
                    [Summary] => 
Two new studies found that daily pills prevented infection with  the AIDS virus in heterosexual men and women in Africa, bringing new  hope for someday offering a medical shield against HIV infection.
                    [DatePublished] => 2011-07-15 02:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 705568
                    [Title] => Pills prevent HIV in straight men and women
                    [Summary] => 
Two new studies found that daily pills prevented infection with the AIDS  virus in heterosexual men and women in Africa, bringing new hope for  someday offering a medical shield against HIV infection.
                    [DatePublished] => 2011-07-13 21:14:04
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

GILEAD SCIENCES INC

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1350193
                    [Title] => FDA approves Gilead Sciences drug for 3 cancers
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer.

                    [DatePublished] => 2014-07-25 07:01:42
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1265295
                    [Title] => FDA approves breakthrough hepatitis C drug
                    [Summary] => 
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.

                    [DatePublished] => 2013-12-07 07:32:52
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1510054
                    [AuthorName] => Matthew Perrone
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img4.imageshack.us/img4/181/l7wd.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 842936
                    [Title] => US approves 4-in-1 HIV combination pill
                    [Summary] => 
The U.S. Food and Drug Administration on Monday approved a new anti-HIV pill that combines four medicines to combat the virus that causes AIDS.
                    [DatePublished] => 2012-08-28 11:21:35
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 836861
                    [Title] => HIV prevention pill for heterosexuals at risk too
                    [Summary] => 
U.S. health officials said Thursday that doctors  should consider giving an AIDS prevention pill to women and heterosexual  men who are at high risk for getting the virus.
                    [DatePublished] => 2012-08-10 01:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 833309
                    [Title] => DOH mulling adoption of preventive medication for HIV
                    [Summary] => 
The Department of Health (DOH) is studying the possibility of adopting preventive medication for HIV/AIDS that was approved by the United States’ Food and Drug Administration.
                    [DatePublished] => 2012-07-31 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 706063
                    [Title] => Pills prevent HIV in straight men and women
                    [Summary] => 
Two new studies found that daily pills prevented infection with  the AIDS virus in heterosexual men and women in Africa, bringing new  hope for someday offering a medical shield against HIV infection.
                    [DatePublished] => 2011-07-15 02:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 705568
                    [Title] => Pills prevent HIV in straight men and women
                    [Summary] => 
Two new studies found that daily pills prevented infection with the AIDS  virus in heterosexual men and women in Africa, bringing new hope for  someday offering a medical shield against HIV infection.
                    [DatePublished] => 2011-07-13 21:14:04
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

abtest